DETECT study shows AI assistance using GI Genius™ reduces missed polyp rate by nearly 50% on initial colonoscopy
Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced topline results from a randomized, international, multi-center study evaluating the safety and efficacy of artificial intelligence (AI) device GI Genius™ as an aid for the detection of colorectal polyps in combination with colonoscopy. The DETECT study was designed to provide evidence of the advantages of using GI Genius™ in the real-time detection of colorectal polyps and to assess if the use of GI Genius™ would decrease the miss rates of colorectal polyps and adenomas when compared to white light endoscopy.